For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
No need to worry: Govt dismisses reports on banning Rs 2,000 note -
Priyanka Chopra's Take On ‘Girl Don’t Yell’ Controversy With Pak Woman: ‘Have Never Been Pro-War’ -
Pakistan vs Sri Lanka, 1st Test: Having Mickey with us is big advantage, says Karunaratne -
Penile Allergy: Causes, Home Remedies And Prevention -
7 Beautiful Churches in India For The Perfect Christmas Holiday -
Airtel Launches VoWiFi Service In Delhi-NCR: List Of Compatible Smartphones -
Orxa Mantis Electric Performance Motorcycle Revealed At India Bike Week 2019 -
TOEFL Go! Global: A Mobile App From ETS To Stand Out In Exam
Aurobindo Pharma continues good show; scrip hits 52-week high
|
Shares of drug maker Aurobindo Pharma extended gain over 5 per cent in early trade on Bombay Stock Exchange (BSE) with the stock touching 52-week high as investors continued to bet on companies robust performance.
The company had reported a robust operating performance for the second quarter ended September 2013 and had also received the final approval from the U.S. health regulator to manufacture and market DuloxetineHydrochloride Delayed-Release capsules, an anti-depressant drug, in the American market.
Continuing its gaining momentum, shares of company gained as much as 5.47 per cent to trade at Rs 404.80 a piece on the BSE.
In a similar fashion, shares of the company advanced 4.43 per cent 400.80 a piece on National Stock Exchange.
Meanwhile, the broader benchmark Sensex was quoting at 21,124.39, down 23.36 points or 0.11 per cent at 10:12 hours.
Dion Global Solutions Ltd.
